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Abstract: In health economic evaluations the quality-adjusted life-year (QALY) is 
one of the preferred outcome measures. Catalogues of median-based decrements in 
EQ-5D-3L index scores for chronic conditions exist to inform economic evaluations 
but may not be appropriate for this purpose as mean, rather than median, EQ-5D-
3L index scores are of primary interest. Firstly, we aim to estimate mean decrements 
in EQ-5D-3L index scores through a simple stratified analysis as an alternative to 
regression modelling. In addition, we aim to estimate the mean decrement in EQ-
5D-3L index scores in percent relative to a disease-free reference population. 
Secondly, we aim to handle both multiple imputation and appropriate estimation of 
standard errors in the presence of individual sampling weights. Data on EQ-5D-3L 
from the National Health Profile, Denmark, 2013, were used to estimate the EQ-
5D-3L index scores. Calculation of decrements in EQ-5D-3L index scores of 
chronic conditions was done while controlling for the additional number of chronic 
conditions beside the one in question, age and sex. Also, a test of homogeneity of 
decrements across subgroups was conducted. We provide a mini-catalogue of new 
percentage-scale decrements in EQ-5D-3L index scores. For example, we estimated 
that angina was associated with an 8.2% reduction in the EQ-5D-3L index score 
compared to a reference group without angina. If the mean EQ-5D-3L score was 
0.848 among corresponding groups without angina; angina patients would have an 
EQ-5D-3L index score of (1-0.082)·0.848=0.778 using the percentage-scale. The 
estimated percentage reduction in the EQ-5D-3L index score was homogenous 
regardless of the number of additional chronic conditions, age and sex. We suggest 
a percentage-scale estimation of EQ-5D-3L index scores for chronic disorders as an 
alternative to existing median-based methods. Our estimates stem from a simpler 
model, which, we argue, is easier to use and interpret. 
 
JEL classification: I1 
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1 Introduction 
In health economic evaluations the quality-adjusted life-year (QALY) is one of the preferred 
outcome measures. The QALY incorporates both quantity and quality of life, thereby 
allowing for comparison across different diseases, including chronic conditions (Brazier et 
al., 2007). The most frequently used instrument to derive QALYs in Western countries is 
the EQ-5D-3L. The EQ-5D-3L is a generic health-related quality of life instrument that has 
been used to describe population health and health outcomes in clinical trials and health 
economic evaluations. The EQ-5D-3L index scores are available with country-specific 
preference weights in 24 countries and regions. In 10 countries including Denmark, the 
values have been derived through the Time Trade-Off (TTO) elicitation method (Szende et 
al., 2014; Wittrup-Jensen et al., 2009). As EQ-5D-3L index scores are not always readily 
available, catalogues have been developed with utility scores for chronic conditions, thereby 
thus making it possible to estimate the loss in health-related quality of life associated with 
a specific disease of interest (Sullivan and Ghushchyan, 2006; Sullivan et al., 2005; Sullivan 
et al., 2011).   
Health economists prefer mean cost and mean QALYs (and hence mean utilities to 
estimate mean QALYs) when the result of, for example, an intervention or a prevention 
programme is presented in a cost utility analysis (CUA) as an incremental cost-effectiveness 
ratio (ICER) because the mean can be interpreted as a per capita measure of cost per QALY 
(Brazier et al., 2007). As pointed out by Pullenayegum and colleagues (Pullenayegum et 
al., 2010), the catalogues referred to above are not based on mean scores but on median 
scores. Sullivan and colleagues used Censored Least Absolute Deviation regression analysis 
(CLAD) because it appears that the EQ-5D-3L is not normally distributed and exhibits a 
significant ceiling effect at 1. Given these factors, CLAD might be the most appropriate 
method of assessing EQ-5D-3L scores (Sullivan et al., 2005). CLAD assumes that the 
observed utilities are censored at 1, and hence that the true utility can be greater than 1. 
However, when the EQ-5D-3L is used for calculation of quality weights conceptually 
bounded by 1 and -1 then the censoring assumption loses its appropriateness (Pullenayegum 
et al., 2010). Pullenayegum and colleagues found that when the censoring assumption is not 
appropriate CLAD is biased – and in fact specified as a median regression (Sullivan and 
Ghushchyan, 2006, p. 417). Based on the work of Pullenayegum et al. we suggest that 
alternatives are tested and median regression eventually is replaced. Ordinary least squares 
(OLS) is an unbiased alternative – at least asymptotically (Pullenayegum et al., 2010). But 
other methods should be tried and results compared. One approach to test is estimation of 
decrements in the preference-based utility index scores on a relative scale instead of the 
absolute scale on which decrements typically are calculated. A relative scale corresponds to 
the ratio of means in contrast to absolute-scale mean differences, that is, the mean EQ-5D-
3L score of the selected population with the disease minus the mean EQ-5D-3L score of the 
corresponding disease-free population.   
The aim of the present paper is to estimate a mini-catalogue of percentage-scale 
mean EQ-5D-3L index scores for 17 common chronic conditions.  
2 Methods 
2.1 Questionnaire data 
For estimation of scores, we utilized data from a health survey answered by 20,220 adults 
in the North Denmark region in 2013, which included self-reported information on 17 
chronic disorders selected independently by the regional health authority as the most 
important chronic conditions of concern. Initially, the survey was sent to a random sample 
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of 35,700 adult citizens of the North Denmark region of which 20,200 (56.6 %) were 
returned. The health survey also included the EQ-5D-3L (Wittrup-Jensen et al., 2009). The 
EQ-5D-3L comprises five dimensions (mobility, self-care, usual activities, pain/discomfort 
and anxiety/depression), each of which has three levels (no problems, moderate problems 
and extreme problems). An individual’s EQ-5D-3L health state can be expressed as a five-
digit health profile by combining the levels in each of the five dimensions; this allows a 
possible 243 health states to be defined (Brooks et al., 2003; Rabin and de Charro, 2001). 
A single index score can be derived for each of these health states by applying preference 
weights obtained from the general population (Szende et al., 2007). Danish EQ-5D-3L 
preference weights have been generated using the TTO valuation technique in a random 
sample from the Danish general population for some of the 243 possible health conditions 
and with different regression methods for the remaining conditions (Wittrup-Jensen et al., 
2009; Wisløff et al., 2014).  
A total of 5,007 of the respondents (25%) had one or more missing answers 
including missing answers to the five questions of the EQ-5D-3L questionnaire (629 
respondents). Therefore, multiple imputation of missing values was performed with the 
STATA 13 procedure “mi impute chained” (StataCorp, 2013). We chose an imputation 
model comprising age, sex, educational level and two questions from the questionnaire 
answered by 99.2% of the study population (“How do you assess your general health?” and 
information on whether any social benefit was received), thereby assuming that the 
probability of missing data is conditionally independent of any unobserved factors given 
knowledge of sex, age, education and answers to the questions mentioned above (Little and 
Rubin, 2002). Handling of individual non-response weights was done as described in 
Kreuter and Valliant (Kreuter and Valliant, 2007). The North Denmark region is one of five 
regions in Denmark and comprises 11 smaller communities. Stratified sampling with 
regards to communities was performed in this study and the way to handle this stratified 
approach is also described in Kreuter and Valliant (Kreuter and Valliant, 2007). 
2.2 Mean decrements 
We aimed to investigate the impact of sex, age and the number of additional chronic 
conditions beside the one in question on mean decrements. It is generally accepted that the 
loss of utility associated with chronic conditions is greater among women, the elderly and 
the chronically ill (Sørensen et al., 2009). We calculated the mean decrements as minus the 
difference between the mean EQ-5D-3L score among respondents with the chronic 
condition in question and the mean EQ-5D-3L score among the remaining respondents 
without the specific condition. Both means were weighted and multiply imputed as 
described in the previous section and the calculation took place in STATA 13 with the 
“mean” procedure followed by the “lincom” procedure, thus estimating the standard error 
of the mean decrement. In order to investigate the effect of sex and age on the mean 
decrements we stratified or subdivided the data into four strata or disjoint parts (for age: 
<65 years and 65+ years). Then for each stratum, we estimated a mean decrement and 
plotted the four numbers per condition. Afterwards we did a similar inspection of the 
marginal effect of the number of additional conditions beside the one in question (0, 1, 2, 3, 
4, 5+ additional conditions); that is, we subdivided the data into six parts, estimated a mean 
decrement in each stratum and plotted the six numbers per condition for comparison.  
2.3 Mean decrements in per cent   
Similarly, we estimated stratum-specific decrements on the relative scale on which we 
compare the ratio of means of the respondents without a disease (nominator) and those with 
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the disease respectively (denominator). The relative-scale decrement is defined as the ratio 
of means minus one multiplied by minus one hundred. However, we did the analysis of the 
ratio on the logarithmic scale. Each stratum-specific ratio of means was transformed with 
the natural logarithmic function because the asymptotic normality of ratio estimates use to 
fit better on the logarithmic scale. The estimation of the log ratios in STATA 13 was 
performed using the “mean” procedure followed by the “nlcom” procedure which utilizes 
the so-called delta method for calculation of standard errors (Kirkwood and Sterne, 2003, 
p. 157).  
2.4 An alternative to regression modelling: stratified analysis 
In epidemiology, stratification by important confounders accompanied by inverse variance 
weighting is a well-known tool of confounder adjustment (Rothman and Greenland, 1998). 
The procedure of weighting together different (stratum-specific) estimates is also used in 
fixed-effects meta-analysis (Kirkwood and Sterne, 2003). In this work, we considered three 
possible confounders: age, sex, and the number of co-morbid chronic conditions beside the 
one in question. Because the percentage-scale decrements cannot be estimated in linear 
regression as the absolute-scale decrements we used the stratified approach here. We now 
describe the alternative approach in details which is also exemplified in the appendix.  
With the aim of adjusting for sex, age (in two categories) and NACC (the number of 
additional conditions beside the one in question, in six categories), we subdivided the data 
into 24 strata corresponding to the triple interaction of the three variables. Then we 
estimated both absolute- and percentage-scale decrements with standard errors in each 
stratum. Firstly, we considered the adjusted relative-scale decrement. As seen in the 
appendix, the weights are the inverse squared standard error (𝑤𝑒𝑖𝑔ℎ𝑡 =
1
𝑆𝐸2
). The stratified 
approach rests upon an assumption of homogeneity of effect in all strata, that is, a similar 
sign and magnitude of decrements in all disjoint subsets of data. This hypothesis can be 
tested by a Chi-square test as found in Kirkwood and Sterne (Kirkwood and Sterne, 2003): 
𝜒2 = 𝑄 = ∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖 ∙ ln(𝑟𝑎𝑡𝑖𝑜𝑖)
2 −
[∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖 ∙ln(𝑟𝑎𝑡𝑖𝑜𝑖)]
2
∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖
,  where the index 𝑖 numbers the 
strata and the degrees of freedom equal the number of strata minus one.  
Secondly, we estimated the common percentage-scale decrement adjusted for sex, 
age and NACC: the common ln(𝑟𝑎𝑡𝑖𝑜) =
∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖 ∙ln(𝑟𝑎𝑡𝑖𝑜𝑖)
∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖
 whereas the standard error was 
estimated as 𝑆𝐸(ln(𝑟𝑎𝑡𝑖𝑜)) =
1
√∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖
. Using the exponential function leads us back to 
the original scale: the common 𝑟𝑎𝑡𝑖𝑜 = exp(𝑙𝑛(𝑟𝑎𝑡𝑖𝑜)). The exponential function can also 
be used on the 95% confidence interval of the common 𝑙𝑛(𝑟𝑎𝑡𝑖𝑜) to get a 95% confidence 
interval of the common 𝑟𝑎𝑡𝑖𝑜. 
The adjusted estimate of the mean decrement on the absolute scale was conducted 
similarly through replacement of ln(𝑟𝑎𝑡𝑖𝑜) with the mean difference in each stratum. The 
standard error is now the standard error of the mean difference, i.e. the absolute-scale 
decrement obtained from STATA 13. The common absolute decrement adjusted for sex, 
age and NACC =
∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖 ∙𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑖
∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖
 and 𝑆𝐸 =
1
√∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖
 as above where again the 
𝑤𝑒𝑖𝑔ℎ𝑡𝑖 =
1
𝑆𝐸𝑖
2  and 𝑆𝐸𝑖 is the standard error of 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑖 in the 𝑖th stratum. Also the 
formula of the homogeneity test is straightforward: 𝜒2 = 𝑄 = ∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖 ∙
𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑖
2 −
[∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖 ∙𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑖]
2
∑ 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑖
, where the term “difference” denotes the absolute-
scale decrement. The degree of freedom is equal to the number of strata minus one.  
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3 Results 
Table 1 shows the descriptive statistics of the weighted and imputed data to the left and 
descriptive statistics of the complete cases to the right. It can be seen from the table that the 
imputed data contained more respondents with chronic conditions (13,365 (66.1%) versus 
9,760 (64.2%)) and that these respondents have lower mean quality of life (total population 
score weighted and imputed of 0.844 versus a score of 0.865 for the un-weighted complete 
cases).  
After multiple imputation was performed, we calculated weighted mean EQ-5D-3L 
scores for respondents with a chronic disease and separately for the remaining respondents 
without the disease for each of the 17 states, respectively. The mean decrement in EQ-5D-
3L score was simply the difference between those means. See Table 2 for an example 
(angina). Here, the mean EQ-5D-3L was calculated for the group of respondents with self-
reported angina (=0.648, also found in Table 1) and the rest without angina, respectively 
(=0.848). We also calculated the ratio of means as seen in the table and transformed the 
ratio by the natural logarithmic function. The standard errors of the mean decrement and the 
log-scale mean ratio were obtained from STATA 13.  
In Figure 1, we show the mean decrements stratified by sex and age (in two 
categories: <65 years and 65+ years) for each of the 17 chronic diseases. There seemed to 
be no effect of sex because the line segments corresponding to a specific disease tended to 
be horizontal and parallel with respect to age. However, a very strong effect of age can be 
seen in the figure. For 14 out of 17 diseases for females, the mean decrement decreased or 
became numerically smaller in the old age category than in the younger group. For the 
males, 16 out of 17 decrements decreased with age. In Figure 2, we stratify by the number 
of additional chronic conditions (NACC) beside the condition in question and show again 
the decrements by NACC (0 additional conditions, 1, 2, 3, 4, 5+). There is a very slight 
decreasing pattern in decrements by NACC; 12 out of 17 diseases tend to decrease by 
NACC. Of the remaining five, only two diseases (asthma and cerebral thrombosis) show a 
strong increasing trend. Only one curve showed a statistically significant effect modification 
by NACC, namely migraine, which may be interpreted as a random finding because the 
corresponding curve is rather flat compared with the others.     
In Table 3, we report both the absolute- and relative-scale mean decrements 
originating from a stratification by sex (2 categories), age (2 categories) and NACC (6 
categories) followed by an inversely weighted average of the 24 mean decrements on either 
the absolute or relative scale. The stratification and weighted average calculation 
corresponds to a linear regression analysis adjusting for the triple interaction of sex, age and 
NACC for the absolute-scale decrement. A linear regression estimation of relative-scale 
decrements is not possible and can be calculated only by the stratification method described 
here. An example of the calculation behind the weighted average is given in the appendix. 
In the appendix, the three sums in 𝑄 are calculated in adjacent columns and finally, used in 
the estimation of Q=10.29 for angina. The p-value= 0.99 is the probability of obtaining the 
value 𝑄 = 10.29 or more in the chi-square distribution with 23 degrees of freedom.  On the 
basis of this large p-value (much larger than 0.05) we cannot reject the null hypothesis of 
homogeneity of the 24 relative decrements in the case of angina. For all 17 chronic 
conditions, we obtained p-values above the significance level of 5% when testing the 
hypothesis of homogeneity of decrements.  
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Table 1: Descriptive statistics of the study population 
 
* Quartiles cannot be computed using sampling weights. NCC=number of chronic conditions. Note, that the values 0 
and 1 are categorized separately. 
Note: Descriptive statistics on the study population both before (to the right) and after (to the left) multiple imputations. 
Number of respondents with a specific chronic condition, prevalence, mean age and EQ-5D-3L, and percentage of 
women were weighted by individual sampling weights. Quartiles and medians (and mean EQ-5D-3L for comparison) 
of the number of chronic conditions (NCC) and EQ-5D-3L score are provided for the complete cases. Data originated 
from 20,220 respondents of a health survey in the North Denmark region in 2013. Missing data were multiply imputed 
and sampling weights appropriately handled through Taylor series expansions (Little and Rubin, 2002, p.53; Kreuter 
and Valliant, 2007, p. 9-12).  
  Weighted and multiply imputed  Complete cases unweighted* 
Chronic condition N % 
mean 
age 
% 
women 
Unadjusted 
mean  
EQ-5D-3L  n % 
NCC 
25% 
NCC 
50% 
NCC 
75% 
median 
EQ-5D-
3L 
Unadjusted 
mean  
EQ-5D-3L 
               
Asthma  1436 7.1 49 60 0.761 889 5.8 2 3 4 0.824 0.802 
Allergy  3761 18.6 47 59 0.821 2665 17.5 1 2 3 0.824 0.839 
Diabetes  1193 5.9 65 48 0.740 669 4.4 2 3 4 0.818 0.781 
Hypertension 4428 21.9 64 50 0.771 3097 20.4 2 2 4 0.824 0.813 
AMI  283 1.4 70 33 0.659 139 0.9 3 4 6 0.723 0.686 
Angina 465 2.3 65 46 0.648 247 1.6 3 4 6 0.723 0.692 
Cerebral thrombosis 364 1.8 68 44 0.621 177 1.2 2 4 5 0.717 0.658 
COPD  1072 5.3 65 47 0.688 574 3.8 2 4 5 0.771 0.735 
Osteoarthritis 4570 22.6 63 58 0.719 3214 21.1 2 3 4 0.776 0.756 
Rheumatoid arthritis 1294 6.4 61 51 0.651 739 4.9 2 4 5 0.756 0.697 
Osteoporosis 829 4.1 71 81 0.672 422 2.8 2 3 5 0.774 0.728 
Cancer  586 2.9 66 50 0.728 400 2.6 2 3 4 0.776 0.773 
Migraine  3073 15.2 46 70 0.742 2161 14.2 1 2 4 0.818 0.780 
Psychiatric disorder 1537 7.6 45 61 0.653 913 6.0 2 3 4 0.756 0.686 
Slipped disk 2912 14.4 55 49 0.695 1970 12.9 2 3 4 0.776 0.728 
Cataracts  1072 5.3 74 59 0.716 548 3.6 2 4 4 0.776 0.775 
Tinnitus  2528 12.5 57 34 0.787 1790 11.8 2 2 4 0.824 0.817 
               
Total population 20220 100 49 50 0.844 15213 100 0 1 2 0.824 0.865 
No chronic conditions 6855 33.9 40 45 0.934 5453 35.8 0 0 0 1 0.938 
At least one condition 13365 66.1 53 53 0.798 9760 64.2 1 2 3 0.824 0.824 
One chronic condition 5197 25.7 46 50 0.879 4232 27.8 1 1 1 0.838 0.886 
Two 3498 17.3 53 52 0.820 2702 17.8 2 2 2 0.824 0.832 
Three 2083 10.3 58 55 0.752 1445 9.5 3 3 3 0.776 0.769 
Four 1213 6.0 62 57 0.693 749 4.9 4 4 4 0.756 0.713 
Five+ 1375 6.8 66 57 0.597 632 4.2 5 5 6 0.708 0.633 
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Table 2:  Estimated mean absolute-scale and mean relative-scale decrements for 
angina. An example 
 Multiply 
imputed and 
weighted mean 
(SE) 
Mean 
decrement (SE) 
Mean ratio Mean ratio on 
log-scale 
(SE) 
Relative-
scale 
decrement 
Respondents 
with self-
reported angina  
0.648 (0.0185) 0.200 (0.0186)    0.764    -0.270 (0.0287) 23.6% 
Respondents 
without self-
reported angina 
0.848 (0.0017) Reference Reference Reference Reference 
Note: Mean EQ-5D-3L scores for respondents with and without self-reported angina respectively. The mean 
decrement in EQ-5D-3L index score is minus the absolute difference between the means similar to what can 
be estimated as decrements in OLS. The relative-scale decrement is the relative difference between the means 
i.e. the mean ratio minus one multiplied by minus 100. The table also reports the mean ratio on the logarithmic 
scale on which the standard error was calculated. Note that both the absolute- and relative-scale decrements 
reported here are large because no confounder adjustment was made. Data from 20,220 respondents of a health 
survey in the North Denmark region, 2013. 
 
 
Figure 1:  Mean decrement in EQ-5D-3L index score by sex and age for 17 common 
chronic conditions 
Note: Estimated mean decrements in EQ-5D-3L index score marginally by the combination of sex and age (in 
two categories: <65 years and 65+ years) for 17 chronic conditions. The well-known pattern of smaller 
decrements in the elderly is recognized from this plot. Only a few chronic conditions (2–3 out of 17) show an 
increasing trend. There are no signs of lower mean decrements for females in this data set after stratification 
by age. Data from 20,220 respondents of a health survey in the North Denmark region, 2013.  
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Figure 2:  Mean decrement in EQ-5D-3L index score by number of additional 
chronic conditions for 17 common chronic conditions 
 
Note: Estimated mean decrements in EQ-5D-3L index score marginally by the number of additional chronic 
conditions (NACC) beside the condition in question for 17 chronic conditions. The picture is rather flat curves 
with a slight decreasing pattern by NACC. Twelve curves show a decreasing trend whereas five curves tend 
to increase. Data from 20,220 respondents of a health survey in the North Denmark region, 2013.  
 
3.1 An example of the application of percentage-scale decrements 
We will give an example of the difference between the absolute- and relative-scale 
decrements and the properties of these two types of application. Let us consider angina in 
Table 3, for which we find a mean decrement of 0.068 whereas the relative decrement was 
estimated to be 8.2%. We calculate the mean EQ-5D-3L index score stratified by NACC in 
the population with no angina and get: 0.934 (NACC=0), 0.879 (NACC=1), 0.820 
(NACC=2), 0.753 (NACC=3), 0.692 (NACC=4) and 0.603 (NACC=5+). The absolute 
mean decrement is interpreted as being a constant 0.068 in all six strata, whereas on the 
relative scale, the decrement can be calculated as 0.934 multiplied by 0.082, which equals 
0.077 (NACC=0), and similarly: 0.072 (NACC=1), 0.067 (NACC=2), 0.062 (NACC=3), 
0.057 (NACC=4) and 0.049 (NACC=5+) decreasingly by the number of co-morbid chronic 
states reflecting the pattern seen in Figure 2. The relative decrements can, in a similar 
manner, reflect the decreasing pattern seen for age in Figure 1. 
The ranking, in Table 3, of the conditions by the absolute magnitude of the 
decrements seems consistent with the severity of the conditions. The worst states are mental 
disorder and cerebral thrombosis, whereas allergy and asthma are the least severe conditions 
according to the percentage-scale. The ranking according to the conventional absolute scale 
was similar.  
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Table 3:  Estimated decrements in mean EQ-5D-3L index score on both absolute 
and relative scale adjusted for sex, age and the number of co-morbid 
chronic conditions 
  Adjusted by stratification*   
 Absolute scale   Relative scale 
Chronic state 
mean 
decrement 
95% CI 
 
mean 
ratio 
95% CI 
 mean 
decrement 
in % 
95% CI 
            
Asthma 0.011 -0.002 0.025  0.989 0.973 1.005  1.1% -0.5% 2.7% 
Allergy 0.000 -0.007 0.006  1.000 0.992 1.007  0.0% -0.7% 0.8% 
Diabetes 0.035 0.022 0.048  0.959 0.944 0.974  4.1% 2.6% 5.6% 
Hypertension 0.022 0.015 0.030  0.975 0.967 0.983  2.5% 1.7% 3.3% 
AMI 0.047 0.019 0.076  0.946 0.911 0.984  5.4% 1.6% 8.9% 
Angina pectoris 0.068 0.043 0.092  0.918 0.888 0.949  8.2% 5.1% 11.2% 
Cerebral 
thrombosis 
0.114 0.088 0.139 
 
0.873 0.843 0.905 
 
12.7% 9.5% 15.7% 
COPD 0.059 0.043 0.076  0.928 0.908 0.948  7.2% 5.2% 9.2% 
Osteoarthritis 0.090 0.082 0.098  0.897 0.889 0.906  10.3% 9.4% 11.1% 
Rheumatoid 
arthritis 
0.100 0.086 0.115 
 
0.881 0.864 0.899 
 
11.9% 10.1% 13.6% 
Osteoporosis 0.071 0.055 0.088  0.918 0.898 0.938  8.2% 6.2% 10.2% 
Cancer 0.061 0.044 0.079  0.928 0.908 0.949  7.2% 5.1% 9.2% 
Migraine 0.072 0.063 0.081  0.920 0.910 0.930  8.0% 7.0% 9.0% 
Mental disorder 0.157 0.143 0.171  0.821 0.806 0.837  17.9% 16.3% 19.4% 
Slipped disk 0.106 0.097 0.116  0.875 0.864 0.887  12.5% 11.3% 13.6% 
Cataracts 0.048 0.030 0.066  0.947 0.926 0.968  5.3% 3.2% 7.4% 
Tinnitus 0.020 0.012 0.028  0.977 0.968 0.986  2.3% 1.4% 3.2% 
             
Note: Estimated decrements in mean EQ-5D-3L index scores on both absolute and relative scale adjusted for 
sex, age and the number of additional chronic conditions beside the state in question. The calculation was 
performed using a stratified approach and involved multiple imputation and appropriate handling of individual 
sampling weights. Data from 20,220 respondents of a health survey in the North Denmark region, 2013. 
*Stratification was done with respect to the number of additional chronic conditions beside the one in question, 
sex, and age (in two categories: <65 years and 65+ years) except for AMI, cerebral thrombosis and 
osteoporosis, which were only adjusted for NACC and age because of scarcity of data in some strata.  
 
4 Discussion 
As something new, this paper presents percentage-scale mean decrements of index scores 
of chronic conditions. These relative decrements may be more homogeneous according to 
age, sex and the degree of co-morbidity (measured as the number of chronic conditions 
beside the one in question). Furthermore, the suggested measures are based on mean 
differences and mean ratios – not median differences as suggested by others (Sullivan et al., 
2005; Sullivan et al., 2011). The work of Pullenayegum and colleagues is essential to daily 
life economic evaluations (Pullenayegum et al., 2010); the solutions offered by this group 
are, however, cumbersome to implement. Pullenayegum et al. point to latent class models, 
two-part models and generalized additive models (Pullenayegum et al., 2010; Pullenayegum 
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et al., 2013) with the aim of modelling the underlying EQ-5D-3L distribution. What we do 
is simpler but rests heavily on an assumption of the appropriateness of the mean as a 
measure of the central tendency in the sampling distribution of EQ-5D-3L – an assumption 
shared with other solutions as well but also an assumption that means less to the economist 
who wants the mean. The mean and median coincide systematically in symmetric 
distributions; in skewed multimodal distributions with a considerable probability mass in 1 
(like the typical EQ-5D-3L distribution), the mean and median only coincide by chance. 
Facing this fact implies discontinuation of the use of censored least absolute deviations 
(CLAD) median regression as argued by Pullenayegum and colleagues (Pullenayegum et 
al., 2010). 
It is recommended that our stratified analysis is repeated in other data sets in order 
to gather information on the validity and reliability of the method. The suggested stratified 
analysis facilitates estimation of relative decrements on the percentage scale which could 
make the work with, for example, Markov models easier when implicit control of the 
number of additional chronic conditions, age and sex is carried out. The application of 
decrements from the original catalogues easily becomes ambiguous because one needs to 
know more about the chronicity of the persons of interest in an evaluation – information 
that of course in some studies is available. The original median-scale decrements vary by 
the total number of chronic conditions of the person in question. The mean decrements that 
we present are invariant, and we have presented a statistical test of the significance of the 
interaction by the number of additional chronic conditions, age and sex. Testing gave for 
our 17 chronic conditions only insignificant p-values after stratification by the three 
variables in 24 strata. We tried to adjust the mean decrements for age and sex but the 
estimates were not homogeneous by test, and we chose to further stratify by the number of 
additional chronic conditions, which is a strong confounder. We decided to skip more socio-
economic variables in our analysis, not only for simplicity, but also because we claim that 
inclusion of many socio-economic variables may thin out the utility loss due to a specific 
chronic condition. Serious disease may affect the socio-economy of the person with the 
disease and we aim to keep, for example, the utility loss caused by a dropout from the work 
force and lower income in the estimate, say, of cerebral thrombosis. 
New catalogues of preference-based index scores for chronic conditions are 
required, i.e. estimated using alternative methods that are able to handle both multiple 
imputation and appropriate estimation of standard errors in the presence of individual 
sampling weights. Our work meets both requests.   
Our mini-catalogue of relative mean decrement EQ-5D-3L index scores only 
comprises 17 chronic conditions, which, of course, is too little. However, the stratified 
analysis could be repeated in data with information on more conditions. On the other hand, 
one might ask whether there exists an upper bound of the number of conditions included in 
one model, and whether it would be more appropriate to estimate the utility loss of a specific 
condition from subject matter data exclusively including only subject matter co-morbidity, 
and thus leaving out all other “competing” chronic conditions. Comparison of the 
catalogued utility estimates by Sullivan and colleagues (Sullivan et al., 2005; Sullivan et 
al., 2011; Sullivan and Ghushchyan, 2006) and our estimates is not straightforward because 
Sullivan and colleagues include the number of chronic conditions in the application of their 
estimates whereas we do not. What we observed in our results were positive signs of all 
decrement estimates. Furthermore, we noticed what we interpret as consistency with respect 
to seriousness of the condition in the ranking of the 17 chronic conditions by magnitude of 
the estimates.  
A limitation of our approach is the lack of a thorough sensitivity analysis of the used 
imputation model. We reran the calculation of scores with a simple imputation model with 
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no other variables than the endogenous five questions of the EQ-5D-3L and the 17 chronic 
conditions. We got a maximal difference between estimates of 0.017 for absolute scale, 2.4 
percent points for relative scale estimates and standard errors of similar magnitude as well. 
Complete case regression analysis (including individual sampling weights) was also 
performed and resulted in maximal differences of 0.025 and 3.5 percent points respectively 
for 16 conditions excluding AMI. For AMI a difference of 0.088 was found between 
absolute estimates, whereas for relative estimates a discrepancy of 9.7 percent points was 
seen. This larger discrepancy was most likely induced by the lack of correction for sex due 
to scarcity of data as mentioned in the footnote of Table 3. The standard errors were slightly 
smaller in the complete data case because the imputation of missing data implies larger 
variation of estimates.  
We should emphasize that the application of the percentage-scale mean decrements 
in EQ-5D-3L index scores becomes easy because they are homogeneous with respect to sex, 
age and the number of chronic conditions (beside the one in question). And we stress that 
decrements on a relative scale are able to reflect the decreasing decrements by, for example, 
age, which is seen empirically.  
5 Conclusion 
This study provided percentage-scale mean decrements of index scores of chronic 
conditions, mean decrements that fit well with empirical research. The decrements were 
estimated with appropriate handling of both multiple imputation of missing data and 
corrections of standard errors in the presence of individual sampling weights.  
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Appendix  
 
Table A1:  Calculation of percentage-scale decrements using stratified analysis 
   mean EQ-5D-3L       
Sex age NACC + angina -angina ratio ln(ratio) SE(ln(ratio) weight weight*ln(ratio) weight*ln(ratio)^2 
M <65 0 0.86 0.94 0.92 -0.08 0.07 178.27 -14.99 1.26 
M <65 1 0.72 0.89 0.81 -0.21 0.07 183.88 -38.07 7.88 
M <65 2 0.70 0.83 0.84 -0.17 0.09 126.43 -21.74 3.74 
M <65 3 0.69 0.73 0.94 -0.06 0.16 41.50 -2.59 0.16 
M <65 4 0.60 0.70 0.85 -0.16 0.21 21.85 -3.49 0.56 
M <65 5+ 0.46 0.60 0.77 -0.26 0.24 17.65 -4.61 1.21 
M 65+ 0 0.88 0.94 0.94 -0.06 0.07 206.58 -13.30 0.86 
M 65+ 1 0.71 0.90 0.79 -0.23 0.13 59.71 -13.85 3.21 
M 65+ 2 0.79 0.83 0.95 -0.05 0.05 360.81 -18.14 0.91 
M 65+ 3 0.75 0.80 0.93 -0.07 0.05 363.87 -25.14 1.74 
M 65+ 4 0.65 0.76 0.86 -0.15 0.10 96.87 -14.30 2.11 
M 65+ 5+ 0.60 0.66 0.92 -0.09 0.07 182.41 -15.95 1.39 
F <65 0 0.91 0.93 0.98 -0.02 0.08 159.14 -3.43 0.07 
F <65 1 0.84 0.87 0.97 -0.04 0.08 175.07 -6.18 0.22 
F <65 2 0.75 0.81 0.92 -0.08 0.05 374.69 -29.26 2.28 
F <65 3 0.65 0.74 0.88 -0.12 0.20 24.74 -3.08 0.38 
F <65 4 0.58 0.63 0.92 -0.09 0.25 16.19 -1.42 0.12 
F <65 5+ 0.47 0.56 0.83 -0.19 0.17 33.93 -6.36 1.19 
F 65+ 0 0.84 0.93 0.91 -0.09 0.07 187.00 -17.31 1.60 
F 65+ 1 0.83 0.87 0.96 -0.04 0.13 61.12 -2.32 0.09 
F 65+ 2 0.66 0.80 0.83 -0.19 0.10 92.39 -17.68 3.38 
F 65+ 3 0.71 0.76 0.94 -0.06 0.08 162.43 -9.23 0.52 
F 65+ 4 0.65 0.70 0.93 -0.08 0.09 116.83 -8.93 0.68 
F 65+ 5+ 0.59 0.60 0.98 -0.02 0.07 219.32 -5.40 0.13 
           
Sum        3462.68 -296.76 35.72 
           
        Q=  10.29 
        df=  23 
        p homogeneity= 0.99 
           
        Estimated ln(ratio)= -0.086 
        SE=  0.017 
        95% CI= -0.119 -0.052 
           
        Estimated ratio= 0.918 
        95% CI= 0.888 0.949 
           
        Estimated rel decrement= 8.21% 
        95% CI= 5.10% 11.22% 
Note: This table exemplifies (for the chosen chronic condition angina) the estimation of percentage-scale mean 
decrements in EQ-5D-3L index score that is described in more detail in the Methods’ section. 
